The Impact of Left Stellate Ganglion Block on Systemic Inflammation and Neuromodulation in CABG Surgery.
1 other identifier
interventional
81
0 countries
N/A
Brief Summary
((82)) patients scheduled to undergo elective CABG by the same surgical team will be allocated randomly by computer-generated random numbers into two equal groups (n= 41). Study groups: Group S (Stellate Ganglion Block Group): Patients will receive an ultrasound-guided Left stellate ganglion block prior to induction of general anesthesia. The block will be performed at the C6 level under strict aseptic precautions using 5 mL of 0.25% bupivacaine. Successful blockade will be confirmed by the appearance of ipsilateral Horner's syndrome. Group C (Control Group): Patients will receive standard perioperative care without stellate ganglion block and will undergo the same anesthetic and surgical management protocol as Group S.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2026
CompletedFirst Posted
Study publicly available on registry
August 20, 2026
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
Study Completion
Last participant's last visit for all outcomes
August 1, 2028
August 20, 2026
August 1, 2026
1.2 years
July 30, 2026
August 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interleukin 6 (IL-6) level in pg/ml change from baseline
0 (baseline) and 6 hours after cardiopulmonary bypass
Secondary Outcomes (9)
1. Incidence of postoperative delirium
day 0 to 3 days after successful extubation
2. Delirium severity will be assessed using the Delirium Rating Scale-Revised-98.
day 0 to 3 days after successful extubation
3. CRP in mg/L, neutrophil to lymphocyte ratio (NLR) and Platelet to white cell ratio (PWR).
day 0 (baseline) to day 3
4. Creatinine baseline level in mg/dl, 24 h postoperatively, 48 h postoperatively, and the urine output was recorded on the first and second postoperative days.
0 (baseline) to 48 hours postoperative
6. Total intraoperative opioid consumption
0 hour From induction of anesthesia to 5 hours after induction of anesthesia
- +4 more secondary outcomes
Study Arms (2)
stellate ganglion block
EXPERIMENTALGroup S (Stellate Ganglion Block Group): Patients will receive an ultrasound-guided Left stellate ganglion block prior to induction of general anesthesia. The block will be performed at the C6 level under strict aseptic precautions using 5 mL of 0.25% bupivacaine. Successful blockade will be confirmed by the appearance of ipsilateral Horner's syndrome.
control
NO INTERVENTIONGroup C (Control Group): Patients will receive standard perioperative care without stellate ganglion block and will undergo the same anesthetic and surgical management protocol as Group S.
Interventions
ultrasound guided left stellate ganglion block in patients undergoing CABG surgery to compare with control group which not receive any block even SHAM block and show its effect on reducing inflammatory biomarkers especially il6 and its effect in reducing postoperative delirium
Eligibility Criteria
You may qualify if:
- All elderly (≥65 years) patients of both genders, as according to the World Health Organization, the chronologic age of 65 years was accepted by most developed countries in the world as a definition of "elderly" or older person. Patients scheduled for elective cardiac surgery under general anesthesia.14
- American Society of Anesthesiologists (ASA) physical status class II or III.
- Patients will be stratified according to their baseline surgical risk utilizing the EuroSCORE II tool \>4%15.
- American Society of Anesthesiologists (ASA) physical status class II or III.
You may not qualify if:
- Pre-existing dementia or significant cognitive impairment.
- History of stroke or cerebrovascular disease.
- Contraindications to SGB (e.g., coagulopathy, local infection, or anatomical abnormalities).
- Preoperative use of antipsychotics or antidepressants.
- Sinus bradycardia \<50bpm \&complete heart block
- BMI\>35
- Redo or emergency surgery.
- On preoperative mechanical ventilation and long sedation time.
- Low EF patients \<35%.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant lecturer of anaesthesiology, intensive care and pain management, faculty of medicine, assiut university
Study Record Dates
First Submitted
July 30, 2026
First Posted
August 20, 2026
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
August 20, 2026
Record last verified: 2026-08